Guidelines for the prevention of stroke in patients with stroke or transient ischemic attack: a guideline for healthcare professionals from the american heart association/american stroke association.
Abstract |
|
Authors | Karen L Furie, Scott E Kasner, Robert J Adams, Gregory W Albers, Ruth L Bush, Susan C Fagan, Jonathan L Halperin, S Claiborne Johnston, Irene Katzan, Walter N Kernan, Pamela H Mitchell, Bruce Ovbiagele, Yuko Y Palesch, Ralph L Sacco, Lee H Schwamm, Sylvia Wassertheil-Smoller, Tanya N Turan, Deidre Wentworth, American Heart Association Stroke Council, Council on Cardiovascular Nursing, Council on Clinical Cardiology, and Interdisciplinary Council on Quality of Care and Outcomes Research |
Journal | Stroke
(Stroke)
Vol. 42
Issue 1
Pg. 227-76
(Jan 2011)
ISSN: 1524-4628 [Electronic] United States |
PMID | 20966421
(Publication Type: Journal Article, Practice Guideline)
|
Chemical References |
- Anticoagulants
- Platelet Aggregation Inhibitors
|
Topics |
- Anemia, Sickle Cell
(complications, therapy)
- Anticoagulants
(adverse effects, therapeutic use)
- Atherosclerosis
(complications, therapy)
- Cerebral Hemorrhage
(complications, therapy)
- Embolism
(complications, therapy)
- Evidence-Based Medicine
- Female
- Foramen Ovale, Patent
(complications, therapy)
- Heart Diseases
(complications, therapy)
- Humans
- Hyperhomocysteinemia
(complications, therapy)
- Ischemic Attack, Transient
(complications, therapy)
- Male
- Platelet Aggregation Inhibitors
(adverse effects, therapeutic use)
- Pregnancy
- Pregnancy Complications, Cardiovascular
(therapy)
- Recurrence
- Risk Factors
- Stroke
(etiology, prevention & control)
- Thrombophilia
(complications, therapy)
- Thrombosis
(complications, therapy)
|
|
Join CureHunter, for free Research Interface BASIC access!
Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease.
Find out why thousands of doctors, pharma researchers and patient activists
around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!
|